Tumor Dormancy and MYC Inactivation: Pushing Cancer to the Brink of Normalcy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 • 5,189 citations
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 • 2,749 citations
Role of angiogenesis in tumor growth and metastasis
2002 • 2,412 citations
Role of angiogenesis in tumor growth and metastasis
2002 • 2,310 citations
Molecular themes in oncogenesis
1991 • 1,663 citations
Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia
2005 • 1,007 citations
Essential role for oncogenic Ras in tumour maintenance
1999 • 880 citations
Reversible Tumorigenesis by MYC in Hematopoietic Lineages
1999 • 871 citations
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
2004 • 842 citations
Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC
2002 • 639 citations
Cancer revoked: oncogenes as therapeutic targets
2003 • 479 citations
Reprogramming of a melanoma genome by nuclear transplantation
2004 • 359 citations
Nuclear Transplantation, Embryonic Stem Cells, and the Potential for Cell Therapy
2003 • 321 citations
Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle
2004 • 270 citations
Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation
2004 • 168 citations
Nuclear cloning of embryonal carcinoma cells
2004 • 167 citations
Tumour dormancy: findings and hypotheses from clinical research on breast cancer
2001 • 148 citations
Integrin α5β1 Promotes Survival of Growth-Arrested Breast Cancer Cells
2004 • 124 citations
Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations
2003 • 117 citations
Nuclear transplantation, embryonic stem cells and the potential for cell therapy
2004 • 78 citations
T-cell immunity in the induction and maintenance of a tumour dormant state
2001 • 65 citations
Defining the temporal requirements for Myc in the progression and maintenance of skin neoplasia
2004 • 64 citations
Conditional animal models: a strategy to define when oncogenes will be effective targets to treat cancer
2004 • 56 citations
Analysis of a “phase transition” from tumor growth to latency
2000 • 56 citations
Dormancy in a model of murine B cell lymphoma
2001 • 45 citations
Brief inactivation of c-Myc is not sufficient for sustained regression of c-Myc-induced tumours of pancreatic islets and skin epidermis.
2004 • 39 citations
STUDIES OF MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOCYTIC LEUKEMIA
2000 • 33 citations
Randomized controlled trial to compare the dose of adjuvant chemotherapy after curative resection of hepatocellular carcinoma
2003 • 25 citations
Advances in follicular lymphoma
2004 • 16 citations
Identification and characterisation of minimal residual disease in solid tumors.
2000 • 7 citations
Cited By (0)
No citing papers found in database